CG
CARMELO GURNARI
Cleveland Clinic, University of Rome Tor Vergata, Università degli Studi di Pavia Facoltà di Medicina e Chirurgia, Bambino Gesù Children's Hospital
0000-0001-6829-5544
Employment
-
University of Rome Tor Vergata Assistant Professor2022 - 2025
-
Cleveland Clinic Research Fellow2019 - Present
-
Bambino Gesù Children's Hospital2015 - 2016
Education
-
University of Rome Tor Vergata Ph.D in Immunology, Molecular Medicine and Applied Biotechnology2020 - Present
-
Università degli Studi di Pavia Facoltà di Medicina e Chirurgia MD2009 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (145)
- PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome Save
- Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients Save
- Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy Save
- Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia: A Real-World Experience Save
- Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response Save
- Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia Save
- What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach Save
- ASSOCIATIONS BETWEEN HLA EVOLUTIONARY DIVERGENCE AND OUTCOME OF MATCHED RELATED OR UNRELATED HCT: A STUDY FROM THE EBMT CELLULAR THERAPY AND IMMUNOBIOLOGY WORKING PARTY Save
- OUTCOME PREDICTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME UNDERGOING HEMATOPOIETIC CELL TRANSPLANT IN THE MOLECULAR ERA OF IPSS- Save
- ROLE OF HLA EVOLUTIONARY DIVERGENCE IN SINGLE HLAMISMATCHED UNRELATED DONOR HCT FOR MALIGNANT HEMATOLOGICAL DISORDERS: A REPORT ON BEHALF OF THE CTIWP OF THE EBMT Save